PMVP 424B3: Secondary offering
Filed with the SEC on · accession 0001193125-26-377000
PMVP filed a 424B3 (prospectus (offering)) with the SEC on Aug 31, 2026. The final terms of an offering of shares or bonds. The stock moved -0.8% by the first close after the filing.
Summary of the filing
PMV Pharmaceuticals terminated its at-the-market offering program under which it could have sold up to $113.8 million of common stock through Jefferies LLC, without having sold any shares.
Key details
How PMVP stock reacted
Close before
$1.22
Aug 28, 2026
First close after
-0.82%
$1.21
5 trading days
+5.74%
$1.29
Since filing
+0.41%
$1.23
✦ Ask GOAX AI about this filing — what it means for PMVP, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for PMVP?
Click hereFrequently asked questions
What did PMVP file with the SEC on Aug 31, 2026?
PMVP filed a 424B3 (Secondary offering). PMV Pharmaceuticals terminated its at-the-market offering program under which it could have sold up to $113.8 million of common stock through Jefferies LLC, without having sold any shares.
What does a secondary offering mean for PMVP stock?
New shares dilute existing holders and are often sold at a discount to the market price.
How do I read a 424B3?
The final terms of an offering of shares or bonds. Look at price, number of shares and the discount to the market price. Large offerings dilute existing shareholders.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 424B3 (prospectus (offering)): The final terms of an offering of shares or bonds.
How did PMVP stock react to this filing?
PMVP closed at $1.22 before the filing and $1.21 on Aug 31, 2026 (-0.82%). Five trading days later: $1.29 (+5.74%).
Other PMVP SEC filings
- 10-Q · SEC filingNov 10, 2026
- 8-K · SEC filingNov 10, 2026
- 8-K · Board changeOct 5, 2026
- 424B5 · Secondary offeringSep 2, 2026
- 8-K · Secondary offeringSep 2, 2026
- 424B5 · Secondary offeringAug 31, 2026
- 8-K · Fda approvalAug 31, 2026
- 10-Q · SEC filingAug 14, 2026
- 8-K · SEC filingAug 14, 2026
- 8-K · Board changeJun 5, 2026
Get alerts when PMVP files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days